Reprogramming glioblastoma multiforme cells into neurons by protein kinase inhibitors
Abstract Background Reprogramming of cancers into normal-like tissues is an innovative strategy for cancer treatment. Recent reports demonstrate that defined factors can reprogram cancer cells into pluripotent stem cells. Glioblastoma multiforme (GBM) is the most common and aggressive malignant brai...
Main Authors: | Jie Yuan, Fan Zhang, Dennis Hallahan, Zhen Zhang, Liming He, Ling-Gang Wu, Meng You, Qin Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-018-0857-5 |
Similar Items
-
Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
by: Hua-fu Zhao, et al.
Published: (2017-06-01) -
Glioblastoma: Molecular Pathways, Stem Cells and Therapeutic Targets
by: Meena Jhanwar-Uniyal, et al.
Published: (2015-03-01) -
Developing the novel bioinformatics algorithms to systematically investigate the connections among survival time, key genes and proteins for Glioblastoma multiforme
by: Yujie You, et al.
Published: (2020-09-01) -
mTOR, autophagy and reprogramming
by: Bor Luen eTang
Published: (2014-01-01) -
Pediatric multifocal glioblastoma multiforme with fulminant course
by: Goutham Cugati, et al.
Published: (2012-05-01)